Innovation Pharmaceuticals Inc (IPIX)

[kfcyahoo]

“Seriously. Does anyone think we cant sell this pipeline for $50M?

Brilacidin is worth $100M on the preclinical antiviral work alone.

The OM phase 2 trial results are probably worth at least $50M as well.

Kevetrin is also likely worth $50M.

Seems way oversold here at $39M if any one of the indications is not a complete fraud. “

One of Kevetrins inventors was paid off, the other sent out to pasture in March, 2018- why?

B is worth 100M yet DeGrad,o and company sold it ~ 8M. We’ll see who was the genius, as someone described the move, in that transaction.

With the account.ant in charge this will continue to go nowhere fast.